Literature DB >> 27320172

Chlamydia trachomatis Genital Tract Infections: When Host Immune Response and the Microbiome Collide.

Noa Ziklo1, Wilhelmina M Huston2, Jane S Hocking3, Peter Timms4.   

Abstract

Genital infections with Chlamydia trachomatis continue to be a major health problem worldwide. While some individuals clear their infection (presumed to be the result of an effective Th1/interferon-γ response), others develop chronic infections and some are prone to repeat infections. In females in particular, chronic asymptomatic infections are common and can lead to pelvic inflammatory disease and infertility. Recent studies suggest that the genital tract microbiota could be a significant factor and explain person-to-person variation in C. trachomatis infections. One hypothesis suggests that C. trachomatis can use its trpBA genes to rescue tryptophan from indole, which is a product of anaerobic members of the genital tract microbiota. Women with particular microbiota types, such as seen in bacterial vaginosis, have increased numbers of anaerobes, and this would enable the chlamydia in these individuals to overcome the host's interferon-γ attempts to eliminate it, resulting in more repeat and/or chronic infections. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lactobacillus; bacterial vaginosis; indole; interferon-γ; sex hormones

Mesh:

Substances:

Year:  2016        PMID: 27320172     DOI: 10.1016/j.tim.2016.05.007

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  31 in total

1.  A bipartite iron-dependent transcriptional regulation of the tryptophan salvage pathway in Chlamydia trachomatis.

Authors:  Nick D Pokorzynski; Amanda J Brinkworth; Rey Carabeo
Journal:  Elife       Date:  2019-04-02       Impact factor: 8.140

2.  Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents.

Authors:  Yan Zhang; Yuqi Xian; Leiqiong Gao; Hiba Elaasar; Yao Wang; Lamiya Tauhid; Ziyu Hua; Li Shen
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 3.  Chlamydia trachomatis: the Persistent Pathogen.

Authors:  Steven S Witkin; Evelyn Minis; Aikaterini Athanasiou; Julie Leizer; Iara M Linhares
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

4.  Microbial Composition Predicts Genital Tract Inflammation and Persistent Bacterial Vaginosis in South African Adolescent Females.

Authors:  Katie Lennard; Smritee Dabee; Shaun L Barnabas; Enock Havyarimana; Anna Blakney; Shameem Z Jaumdally; Gerrit Botha; Nonhlanhla N Mkhize; Linda-Gail Bekker; David A Lewis; Glenda Gray; Nicola Mulder; Jo-Ann S Passmore; Heather B Jaspan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

5.  Presence of Chlamydia trachomatis DNA in the amniotic fluid in women with preterm prelabor rupture of membranes.

Authors:  Marian Kacerovsky; Roberto Romero; Lenka Pliskova; Radka Bolehovska; Helena Hornychova; Adela Matejkova; Hana Vosmikova; Ctirad Andrys; Martina Kolackova; Piotr Laudański; Vera Pelantova; Bo Jacobsson; Ivana Musilova
Journal:  J Matern Fetal Neonatal Med       Date:  2019-07-15

Review 6.  Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections.

Authors:  Susan Tuddenham; Jacques Ravel; Jeanne M Marrazzo
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

7.  In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp.

Authors:  Noa Ziklo; Wilhelmina M Huston; Kuong Taing; Mohammad Katouli; Peter Timms
Journal:  BMC Microbiol       Date:  2016-12-03       Impact factor: 3.605

8.  Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

Authors:  Luis M de la Maza; Toni L Darville; Sukumar Pal
Journal:  Expert Rev Vaccines       Date:  2021-04-28       Impact factor: 5.217

9.  Identifying HLA DRB1-DQB1 alleles associated with Chlamydia trachomatis infection and in silico prediction of potentially-related peptides.

Authors:  Leidy Pedraza; Milena Camargo; Darwin A Moreno-Pérez; Ricardo Sánchez; Luisa Del Río-Ospina; Indira M Báez-Murcia; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

Review 10.  Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota.

Authors:  Michail Karavolos; Alina Holban
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.